prikaz prve stranice dokumenta Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
  Preuzmi
PDF 251.58 KB
Znanstveni rad - Ostalo
Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
Diabetology, 4 (2023), 4; 553-559. https://doi.org/10.3390/diabetology4040049
Golčić, Marin; Belančić, Andrej

Citirajte ovaj rad

Golčić, M. i Belančić, A. (2023). Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology, 4. (4), 553-559. doi: 10.3390/diabetology4040049

Golčić, Marin i Andrej Belančić. "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?." Diabetology, vol. 4, br. 4, 2023, str. 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, Marin i Andrej Belančić. "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?." Diabetology 4, br. 4 (2023): 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, M. i Belančić, A. (2023) 'Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?', Diabetology, 4(4), str. 553-559. doi: 10.3390/diabetology4040049

Golčić M, Belančić A. Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology [Internet]. 07.12.2023. [pristupljeno 16.11.2024.];4(4):553-559. doi: 10.3390/diabetology4040049

M. Golčić i A. Belančić, "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?", Diabetology, vol. 4, br. 4, str. 553-559, Prosinac 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:421839. [Citirano: 16.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:421839
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
AutorMarin Golčić
AutorAndrej Belančić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za farmakologiju)
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za onkologiju i radioterapiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Similar microorganisms, via similar mechanisms, play a role in the development of both pancreatic cancer (PC) and type 2 diabetes (T2D). Since the new onset of T2D is potentially one of the earliest signs of PC, it is highly plausible that a common denominator might be responsible for both, as the growth of the cancer will take a longer time to manifest compared to the insulin resistance. Although a variety of host-dependent factors and susceptibility play a role, and the mechanisms connecting the two diseases remain poorly understood, future well-designed trials should hypothesize whether a microbial intervention (modification and/or transplantation) results in a lower incidence and the better treatment of both diseases since the T2D–PC–gut microbiome interconnection seems scientifically logical.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Ostalo
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaDiabetology
Brojčani podacivol. 4, br. 4, str. 553-559
e-ISSN2673-4540
DOIhttps://doi.org/10.3390/diabetology4040049
URN:NBNurn:nbn:hr:184:421839
Datum objave publikacije2023-12-07
URL dokumentahttps://www.mdpi.com/2673-4540/4/4/49
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2023-12-08 14:06:20